Back

Related Content

We make UCL’s research physical and life sciences ideas happen.

News

News

Orchard Therapeutics presents additional positive data regarding MPS-IH

Learn More

News

New hope for Niemann-Pick Disease Type C treatment as Bloomsbury Genetic Therapies receives Orphan Drug Designations

Learn More

News

UCLB spinout Orchard Therapeutics to be acquired by Kyowa Kirin for $477m

Learn More

News

Bramble Energy reveals world’s ‘lowest cost’ hydrogen fuel cell

Learn More

News

The Times names UCL University of the Year 2024

Learn More

News

UCL partner Apollo Therapeutics receives $226.5m to translate medical research into treatments

Learn More

News

Phasecraft raises £13m, led by Playground Global, to become the first to reach practical quantum advantage

Learn More

News

UCL backed tumour-busting cancer therapy cleared for clinical trials

Learn More

News

Investor Q&A: Barny Cox

Learn More

News

Treatment for infantile neuroaxonal dystrophy a step closer as Bloomsbury Genetic Therapies receives Orphan Drug Designations

Learn More

News

New Alzheimer’s hope as UCLB spinout AstronauTx closes $61m Series A financing

Learn More

News

Bloomsbury Genetic Therapies Receives Rare Pediatric Disease Designation from the U.S. FDA for BGT-INAD for the Treatment of Infantile Neuroaxonal Dystrophy (INAD) and Announces Upcoming Type B Pre-IND Meeting with the U.S. FDA

Learn More

News & Stories

Filter

Insights

World Cancer Day 2023 – Q&A with Amit Nathwani

Insights

Q&A with Mark Dickinson, CEO, Intrinsic

Insights

Investor Q&A: Leigh Brody

Insights

Meet Sebastian Hunte, UCLTF Investor

Insights

UCL Technology Fund Showcase 2022

Insights

Investor Q&A: Simon Goldman

Insights

International Women’s Day 2022

Insights

We’re hurtling towards a computing impasse – the investments we make now will define our future

Insights

Meet Pauline Stasiak, UCLTF Investor

See more

Let’s Talk

UCLTF offers investment throughout the spinout journey. We fund proof-of-concept and development projects, and support academics with company formation. We take applications year-round.

Learn More